Red and infrared light therapy for neck pain is one option people reach for when medication, injections, and physical therapy have helped only so much. If you are living with persistent neck pain and weighing whether this therapy is worth trying, what matters is whether the evidence holds up for your kind of neck pain, and that varies more than most sources admit. Red light therapy, known clinically as photobiomodulation, works differently from drugs or injections: it acts on the biology driving the pain rather than masking the signal. This guide reviews what the research shows across each major cause of neck pain, how strong that evidence is, and where it has not yet arrived.
This article is the hub for our complete guide to red and infrared light therapy for neck pain. For condition-specific studies, mechanisms, clinical evidence, safety data, and device considerations, follow the links to each deep-dive article throughout.
Key Takeaways
- Published in The Lancet: A 2009 meta-analysis of 16 randomized controlled trials found low-level laser therapy maintained pain reduction for up to 22 weeks in chronic neck pain, and that patients were about four times more likely to achieve relief than with placebo.
- Ranked first among six physical therapies: A 2025 network meta-analysis in the European Spine Journal compared six physical-therapy modalities head-to-head and ranked high-intensity laser therapy first for neck pain reduction, ahead of shockwave therapy, interferential current, TENS, low-level laser therapy, and ultrasound. Both laser types outperformed placebo.
- Effective across several neck pain conditions: Human clinical-trial evidence exists for myofascial pain, chronic nonspecific neck pain, cervical spondylosis, cervical radiculopathy, and facet joint dysfunction, with the strongest base in myofascial and chronic nonspecific neck pain.
What Neck Pain Does and Why Current Options Leave a Gap
Neck pain is one of the most common chronic pain problems, and most people cycle through the standard options before looking further. The cervical spine is an unusual engineering problem: seven vertebrae carry the full weight of the head while allowing more movement than any other spinal region. Discs, facet joints, nerve roots, muscles, and ligaments are packed into a small space, so pain can come from several sources at once. A person told they have "neck pain" may have degenerating discs, inflamed facet joints, tight muscles with trigger points, a compressed nerve root, or some combination.
The standard path treats each problem separately, and each option has limits. Anti-inflammatories reduce inflammation during flare-ups but carry stomach, heart, and kidney risks with sustained use and do not slow the degeneration in the disc or joint. Muscle relaxants ease spasm but cause drowsiness and do not resolve the trigger points generating the tension. Cortisone injections give temporary relief but lose effect with repeated use. Physical therapy strengthens the neck and restores movement, and it genuinely helps, but it cannot directly reduce the inflammation inside the disc, joint, or nerve root.
That gap, between managing symptoms and acting on the biology, is where the photobiomodulation research is strongest. The therapy reaches the cellular level: restoring energy production in inflamed, depleted tissue, lowering the inflammatory signals that drive degeneration, calming pain signaling at the nerve, and slowing the breakdown of cartilage and disc tissue. The foundations are covered in our guide to how red light therapy works. The question for neck pain is how those mechanisms meet the specific anatomy of the cervical spine.
Most of my patients with persistent neck pain have been through anti-inflammatories, injections, physical therapy. Those have a real role, but they're managing symptoms. What caught my attention with photobiomodulation is the Lancet data showing chronic pain reduction lasting months beyond placebo, combined with the laboratory work on inflammation and tissue breakdown. For patients who've already optimized exercise and manual therapy and still have pain, I think it's a reasonable next step.— Dr. William Carter, MD
How Red Light Therapy Works for Neck Pain
Red light at wavelengths between 630 and 660 nm is absorbed by an enzyme inside the cell's energy factories (the mitochondria), which increases the energy a cell can produce in tissue that chronic inflammation has left depleted, while lowering inflammatory signaling and oxidative stress and improving the tissue's capacity to repair itself (Hamblin, 2017). For the cervical spine, this means the cartilage cells in the facet joints, the cells that maintain disc integrity, and the muscle cells locked in trigger points can return toward normal function.
The disc-protection evidence comes from laboratory studies of human cells. Hwang et al. (2018) found that, in cells from the soft inner core of human discs, red light at 630 nm reduced the enzymes that break tissue down, in a dose- and wavelength-dependent way. A follow-up study (Hwang et al., 2020) tested cells from the tough outer ring of the disc under conditions made to mimic degeneration, and found red light at 645 nm reduced the inflammation signals, the tissue-degrading enzymes, and the pain-related nerve factors that drive disc breakdown. Both are early laboratory findings in isolated human cells, not yet tested in a living human neck. But they show the wavelengths used in red-light devices acting directly on disc biology.
(For the complete evidence on red light mechanisms, see Red Light Benefits for Neck Pain.)
How Infrared Light Therapy Works for Neck Pain
Near-infrared light at wavelengths between 808 and 1064 nm reaches deeper than red light, into the discs, facet joints, nerve roots, and deep neck muscles where neck pain originates. A 2025 computer-simulation study by Chen et al. modeled how light moves through the spine in a rat model. It found that more light reaches the cervical level than the thoracic level, which suggests the neck is relatively accessible to light therapy. Of the wavelengths tested, 1064 nm went deepest. As a simulation in an animal model, it points the direction rather than measuring a clinical dose in humans.
Infrared light also appears to act directly on pain signaling. A laboratory study by Chow and Armati (2007) found that, in rat pain-sensing nerve cells, near-infrared light at 830 nm blocked the fast transport of signals along the small and medium fibers that carry pain, an effect that was dose-dependent and reversible. This offers a mechanistic explanation for the rapid relief sometimes seen in clinical trials, though it is an infrared (not red) wavelength tested in rat cells, and has not been confirmed in human cervical nerves.
This deeper reach matters because the structures behind chronic neck pain sit beneath layers of muscle, fascia, and skin. A randomized controlled trial by Venosa et al. (2019) applied high-intensity 1064 nm laser to patients with cervical spondylosis and found significant reductions in pain and disability, plus improved range of motion, compared with combined ultrasound and TENS. Yilmaz et al. (2020) found similar results for cervical disc-related pain: 1064 nm laser plus exercise improved range of motion and quality of life by reducing pain, compared with standard electrotherapy.
(For the complete evidence on infrared light mechanisms, see Infrared Light Benefits for Neck Pain.)
What the Clinical Evidence Shows
The clinical evidence for photobiomodulation in neck pain spans more than two decades and several review levels: network meta-analyses, systematic reviews and meta-analyses, and individual RCTs across multiple countries.
The 2009 Chow et al. meta-analysis in The Lancet remains a cornerstone. It pooled 16 RCTs with 820 participants, most using infrared laser at 780, 820–830, or 904 nm. Low-level laser therapy reduced chronic neck pain by an average of 19.9 mm on a 100 mm scale versus placebo. Disability improved significantly too, and the relief lasted up to 22 weeks after treatment ended. The trials varied in dose, and adequately dosed protocols clearly outperformed underpowered ones; the practical dose-and-device details are covered in the LED vs. Laser for Neck Pain review.
The 2025 Hao et al. network meta-analysis in the European Spine Journal compared six physical-therapy modalities directly against each other and against placebo. High-intensity laser therapy ranked first for pain reduction, followed by shockwave therapy, interferential current, TENS, low-level laser therapy, and ultrasound. Both laser types outperformed placebo.
For myofascial neck pain specifically, Tehrani et al. (2022) pooled 13 RCTs of low-level laser therapy and found significant improvements in pain, disability, how much pressure it takes before a spot hurts, and range of motion. Alayat et al. (2022) pooled 17 studies covering 944 patients with upper-trapezius pain and confirmed photobiomodulation reduced pain and trigger-point tenderness. Cidral-Filho et al. (2024) reviewed 36 clinical studies of photobiomodulation for neck and shoulder pain, with promising results for pain relief and function.
A randomized controlled trial by Kenareh et al. (2021) compared high-intensity laser therapy with ultrasound-based physiotherapy in office workers with chronic nonspecific neck pain and found laser therapy reduced pain and disability significantly more across all measures. Rampazo et al. (2024), in a double-blind sham-controlled trial, found both photobiomodulation and TENS reduced chronic neck pain during movement, each outperforming sham.
(For the complete clinical evidence, see PBM for Neck Pain: Clinical Evidence.)
Which Types of Neck Pain Respond Best, and Where Is the Evidence Still Building?
Neck pain has multiple causes, and the evidence varies by condition. The ratings below indicate the strength of the science for each:
★★★★★ Gold Standard: Multiple human RCTs, systematic reviews, or meta-analyses with consistent findings.
★★★★ Strong: At least one well-designed human RCT, or multiple controlled studies with significant outcomes.
★★★ Moderate: Human clinical studies with positive outcomes, supported by strong animal or cell-level evidence.
★★ Emerging: Strong biological rationale with limited condition-specific clinical data.
Myofascial Pain Syndrome (Trapezius / Neck) — ★★★★★ Gold Standard
This is where the evidence is deepest. Two condition-specific meta-analyses and multiple positive RCTs, for both low-level and high-intensity laser, support photobiomodulation for myofascial neck pain. Tehrani et al. (2022) found significant improvements in pain, disability, pressure tenderness, and range of motion. Alayat et al. (2022) confirmed reduced pain in upper-trapezius trigger points.
Individual trials reinforce this. Dundar et al. (2015), in a double-blind placebo-controlled study, found high-intensity laser significantly reduced pain and improved neck disability in trapezius myofascial pain. Ahi and Sirzai (2022) compared high-intensity laser with dry needling and found both effective, with laser offering a non-invasive option. In a related study on jaw (TMJ) myofascial pain, Attiyah et al. (2025) compared 980 nm and 635 nm lasers and found both effective, with the 980 nm wavelength producing greater pain reduction. That trial targeted the jaw rather than the neck, but the underlying myofascial pain biology is the same.
What to expect: The pooled data consistently show significant pain reduction within the treatment period, typically 2–4 weeks of regular sessions. Reduced pressure tenderness suggests the therapy is calming the trigger point itself rather than masking it, and range-of-motion gains tend to follow once the pain drops. For trapezius or cervical myofascial pain, expect meaningful relief within the first two weeks and steady improvement over 4–6 weeks. The strongest results came from trials that paired the therapy with exercise and manual therapy rather than using it alone.
Chronic Nonspecific Neck Pain — ★★★★ Strong
The Lancet meta-analysis anchors this. Chow et al. (2009) found that across placebo-controlled RCTs, low-level laser reduced chronic neck pain by an average of 19.9 mm on the 100 mm scale, a clinically meaningful difference, with effects persisting up to 22 weeks after treatment ended. Recent RCTs extend this: Kenareh et al. (2021) found high-intensity laser more effective than ultrasound-based physiotherapy; Momenzadeh et al. (2022) confirmed significant pain reduction versus sham; and Tasca et al. (2023) found photobiomodulation effective in a randomized trial.
The first direct human test of a red LED device for the neck comes from a 2025 pilot study by Jiang et al. This was a small, self-controlled pilot with no placebo group: pain and neck-function scores stayed flat during a four-week no-treatment wait, then improved after four weeks of using a wearable 660 nm red-light device, and a chemical the body uses to signal pain (substance P) decreased. It is a promising first human signal for red LED specifically, not proof, and it sits alongside the larger laser evidence rather than replacing it.
Pain reduction typically begins within the first 1–2 weeks of regular treatment. The Lancet data suggest improvements can persist for months after a treatment course. Functional gains (less stiffness, better movement, easier daily activity) tend to follow pain relief by 1–2 weeks. What the trials have not yet answered is whether the 22-week persistence the Lancet found represents a lasting biological change or a slowly fading treatment effect.
Cervical Spondylosis / Cervical Osteoarthritis — ★★★ Moderate
Multiple positive RCTs support photobiomodulation here, though no meta-analysis exists for this specific condition. Ozdemir et al. (2001), in a double-blind placebo-controlled trial, found low-power laser significantly improved pain, muscle spasm, neck curvature, range of motion, and overall function, with no improvement in the placebo group. Venosa et al. (2019) found high-intensity 1064 nm laser significantly outperformed combined ultrasound and TENS for pain, disability, and range of motion. Haladaj et al. (2017) found high-intensity laser combined with cervical traction effective.
The mechanism evidence supports these findings: in laboratory studies, photobiomodulation reduces the same inflammation signals and cartilage-degrading enzymes that drive joint degeneration. Trials show significant pain and disability improvements within 4–6 weeks, with consistent range-of-motion gains. The therapy addresses the inflammatory component; it does not reverse structural damage already present. For cervical spondylosis, it can reasonably be expected to reduce pain, improve mobility, and reduce reliance on anti-inflammatory medication, which for someone taking daily NSAIDs to function is a practical outcome worth weighing.
Cervical Radiculopathy / Disc Herniation — ★★★ Moderate
The evidence is anchored by targeted RCTs for nerve-related neck and arm pain. Konstantinović et al. (2010), in a double-blind placebo-controlled RCT for acute neck pain with radiculopathy, found significant arm-pain reduction with low-level laser. Ince et al. (2023), in a 90-patient RCT in the American Journal of Physical Medicine and Rehabilitation, found high-intensity laser plus exercise significantly more effective than exercise alone or placebo for arm pain, neuropathic pain, disability, and quality of life, with benefits sustained at 12 weeks. A 2025 systematic review with meta-analysis by de la Barra Ortiz et al. found high-intensity laser produced significant pain improvements in spinal radiculopathy.
At the disc level, the laboratory work of Hwang et al. (2018) showed red light reduced tissue-degrading enzyme activity in human disc cells, offering molecular support for why the therapy may help disc-related problems beyond pain relief alone.
The therapy reduces the inflammation that sensitizes the compressed nerve root, though it does not reverse a disc herniation. Trials show significant reduction in radiating arm pain, with improvements in neuropathic pain and overall disability typically evident within 3–4 weeks. The Ince et al. trial is particularly worth noting: 90 patients, 12-week sustained benefit, and the combination with exercise outperformed both exercise alone and placebo on every measure they tested.
Cervical Facet Joint Syndrome — ★★ Emerging
The evidence rests on one well-designed RCT plus supporting mechanism data. Saayman et al. (2011) tested chiropractic manipulation combined with low-level laser for cervical facet dysfunction; the combination was significantly more effective than either treatment alone for pain, disability, and movement. Liebert and Bicknell (2017) reported on a cohort of cervicogenic-headache patients (driven by upper-cervical facet inflammation) treated with photobiomodulation and physiotherapy, reporting a high short- and medium-term response rate.
The limited evidence suggests photobiomodulation can meaningfully add to manual therapy and exercise for facet-related neck pain. The biological rationale is strong, since the same anti-inflammatory and pain-modulating mechanisms apply, but more targeted trials are needed before this reaches the certainty of the conditions above.
Whiplash-Associated Disorders — ★★ Emerging
Direct evidence for whiplash is limited and mixed. The Bone and Joint Decade Task Force on Neck Pain (Hurwitz et al., 2008) listed low-level laser among effective noninvasive interventions for neck pain generally. However, the OPTIMa clinical practice guideline (Côté et al., 2016) did not find sufficient evidence to recommend laser therapy specifically for whiplash-associated disorder grade III.
The discrepancy likely reflects dosing: many older whiplash studies used parameters now considered subtherapeutic. Whiplash involves acute inflammation, muscle spasm, and often facet-joint involvement, all targets photobiomodulation addresses in other conditions. But the whiplash-specific evidence base has not caught up, and it would be wrong to borrow the confidence from myofascial or chronic nonspecific pain and apply it here without the trials to support it.
Is Light Therapy Safe for Neck Pain Patients?
The safety record across the neck pain literature is consistent: photobiomodulation carries minimal risk. The 2009 Lancet meta-analysis reported only mild, transient side effects (tiredness, nausea, headache, or brief pain increase), with side effects no different from placebo across all 16 trials. Cidral-Filho et al. (2024) reviewed photobiomodulation for neck and shoulder conditions and described it as a safe, non-invasive option. The broader evidence base is large: a 2025 umbrella review by Son et al. examined photobiomodulation across 204 randomized trials and more than 9,000 participants spanning 15 conditions. No serious adverse events have been attributed to photobiomodulation in any neck-pain-specific trial.
The therapy is non-invasive, drug-free, and can be used alongside exercise, manual therapy, TENS, and standard medical care.
(For the complete safety evidence, see PBM Safety for Neck Pain.)
Can You Use an LED Device Instead of a Clinical Laser?
Most neck pain studies used clinical lasers, both low-level (cold) lasers and high-intensity lasers, and most of the strongest evidence, including the Lancet meta-analysis, used infrared laser rather than red LED. That distinction matters when judging a home device. The biological response to light depends on wavelength, dose, and tissue exposure rather than on whether the light is coherent (laser) or non-coherent (LED), a principle established in photomedicine, but the direct human evidence for a red LED device on the neck is, so far, limited.
The 2025 Jiang et al. pilot is the first human test of a wearable 660 nm red-light LED device for neck pain, and it found improvements in pain and neck function, though as a small self-controlled pilot with no placebo group, it is an early signal rather than proof. A 2026 RCT by Trindade et al. found LED photobiomodulation using combined 850 nm and 660 nm clusters significantly reduced pain in temporomandibular-disorder patients, a condition involving some of the same muscles and nerve pathways as the neck, though not the neck itself. The honest summary: the laser evidence is strong, the LED evidence is promising but thinner, and the modality that topped the head-to-head ranking was a clinical laser, not a home LED.
For how these principles translate into a device used on the neck, see how CuraYou's ProWave Deep Healing Pad applies red and infrared light therapy to the cervical area, and the full LED vs. Laser for Neck Pain review.
Where the Evidence Stands, and Where It Does Not
The clinical evidence for photobiomodulation in myofascial neck pain and chronic nonspecific neck pain is robust: a Lancet-published meta-analysis, a 2025 network meta-analysis ranking high-intensity laser first among six modalities, condition-specific meta-analyses, and multiple positive RCTs. For cervical spondylosis and radiculopathy, positive RCTs exist with significant outcomes. For facet joint syndrome and whiplash, the evidence is more limited.
Conclusion: Applying the Research
The evidence establishes that photobiomodulation works for neck pain across multiple conditions, and that treatment parameters determine outcomes. The 2009 Lancet meta-analysis found that adequately dosed protocols succeeded where underpowered ones failed, using infrared wavelengths in the 780–904 nm range; the 2025 network meta-analysis confirmed that both high-intensity and low-level laser significantly outperform placebo. Neck treatment requires coverage across the cervical muscles and spine, not a single point of contact. The practical wavelength-and-dose discussion lives in the LED vs. Laser for Neck Pain review.
Red and infrared light therapy acts on several biological drivers of neck pain at once: cellular energy depletion in chronic inflammation, inflammatory signaling in disc and joint tissue, tissue-degrading enzyme activity in degenerating structures, trigger-point pathology, and pain signaling at the nerve. It does not reverse advanced structural damage, and it does not replace medical management. But across more than two decades of research, the evidence shows it is among the most effective non-drug options for neck pain, with a safety profile that allows sustained daily use.
For related conditions, see our reviews of red light therapy for osteoarthritis and red light therapy for inflammation.
